Search Results - "FOURRIER‐RÉGLAT, A."

Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials by Salvo, F, Fourrier‐Réglat, A, Bazin, F, Robinson, P, Riera‐Guardia, N, Haag, M, Caputi, AP, Moore, N, Sturkenboom, MC, Pariente, A

“…As part of the Safety of Non‐Steroidal Anti‐Inflammatory Drugs (SOS) Project, we reviewed the incidence of cardiovascular (CV) and gastrointestinal (GI) events…”
Get full text

Sudden cardiac and sudden unexpected death related to antipsychotics: A meta-analysis of observational studies by Salvo, F, Pariente, A, Shakir, S, Robinson, P, Arnaud, M, Thomas, SHL, Raschi, E, Fourrier-Réglat, A, Moore, N, Sturkenboom, M, Hazell on behalf of Investigators of the ARITMO Consortium, L

“…To estimate the risk of sudden cardiac death (SCD) or sudden unexpected death (SUD) related to individual antipsychotics, a meta‐analysis of observational…”
Get full text

Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort by Carrière, I., Farré, A., Norton, J., Wyart, M., Tzourio, C., Noize, P., Pérès, K., Fourrier-Réglat, A., Ancelin, M. L.

“…Summary In this population-based elderly cohort, participants using selective serotonin reuptake inhibitor (SSRI) antidepressants have an increased risk of…”
Get full text

Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors by PARIENTE, A, FOURRIER-REGLAT, A, BAZIN, F, DUCRUET, T, DARTIGUES, J. F, DRAGOMIR, A, PERREAULT, S, MOORE, N, MORIDE, Y

“…To determine the effect of treatment gaps on the risk of institutionalization or death among community-dwelling elderly patients treated with cholinesterase…”
Get full text

Agreement between hospital discharge diagnosis codes and medical records to identify metastatic colorectal cancer and associated comorbidities in elderly patients by Gouverneur, A, Dolatkhani, D, Rouyer, M, Grelaud, A, Francis, F, Gilleron, V, Fourrier-Réglat, A, Noize, P

“…Quality of coding to identify cancers and comorbidities through the French hospital diagnosis database (Programme de médicalisation des systèmes d'information,…”
Get more information

Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France by Amadeo, B., Dumartin, C., Robinson, P., Venier, A.G., Parneix, P., Gachie, J.P., Fourrier-Réglat, A., Rogues, A.M.

“…Hospitals in France are encouraged to monitor antibiotic consumption (AbC) and it is known that this differs among hospitals. The aim of the current study was…”
Get full text

When Patients Report Diseases That Prescribers Seem Unaware of: Discordance Between Patient and Physician Reporting of Risk-Related Previous History in NSAID Users From the CADEUS Study by Fourrier‐Réglat, A, Lacoin, L, Pariente, A, Lassalle, R, Robinson, P, Droz‐Perroteau, C, Bégaud, B, Blin, P, Moore, N D

“…Prescribers are often unaware of possibly dangerous previous medical histories (PMHs) of their patients. Data from a study of nonsteroidal anti‐inflammatory…”
Get full text

Factors Associated with the Prevalence of Antibiotic Use for the Treatment of Hospital-Acquired Infections at 393 French Hospitals: A Regional Variation Analysis by Amadeo, B., Dumartin, C., Venier, A. G., Fourrier-Réglat, A., Coignard, B., Rogues, A. M.

“…Objective. The present study investigated regional variations in antibiotic use for the treatment of hospital-acquired infections (HAIs) in France by means of…”
Get full text

NSAIDs discontinuation and myocardial infarction by SALVO, F., PARIENTE, A., NOIZE, P., FOURRIER‐RÉGLAT, A., MOORE, N.

Get full text

KNOWLEDGE, ATTITUDE AND PRACTICE OF HEALTH CARE PROFESSIONALS REGARDING PHARMACOVIGILANCE IN SOUTH-SOUTH NIGERIA by AO, Opadeyi, A, Fourrier-Réglat, AO, Isah

“…Background: In Nigeria, reporting pharmacovigilance issues including adverse drug reactions (ADRs) from health facilities is encouraged especially by health…”
Get full text

Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation by Fayon, M, Girodet, P.O, Pollet, C, Fourrier-Réglat, A, Daveluy, A, Haramburu, F, Tabarin, A, Molimard, M

Get full text

Antidepressants: general practitioners' opinions and clinical practice by Rambelomanana, S., Depont, F., Forest, K., Hébert, G., Blazejewski, S., Fourrier-Réglat, A., Molimard, M., Moore, N.

“…Objective:  To describe and compare general practitioners’ (GPs) opinions on antidepressant drugs and their prescriptions to depressed patients. Method: …”
Get full text

Pattern and evolution of the prescription of olanzapine during one year: Results of the cohort study ECOL by Gasquet, I, Flandre, P, Heurtebize, N, Deal, C, Perrin, E, Chartier, F, Fourrier-Réglat, A

“…The necessary evidence of new therapies of clinical interest extends beyond clinical trials in a less controlled population and closer to clinical practice…”
Get more information

Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France by Bezin, J., Pariente, A., Lassalle, R., Dureau-Pournin, C., Abouelfath, A., Robinson, P., Moore, N., Droz-Perroteau, C., Fourrier-Reglat, A.

“…Purpose The recommended pharmacotherapy for secondary prevention of acute coronary syndrome (ACS) is long-term treatment with a combination of four therapeutic…”
Get full text

KNOWLEDGE, ATTITUDE AND PRACTICE OF HEALTH CARE PROFESSIONALS REGARDING PHARMACOVIGILANCE IN SOUTH-SOUTH NIGERIA by A, Fourrier-Réglat, AO, Isah

“…Background: In Nigeria, reporting pharmacovigilance issues including adverse drug reactions (ADRs) from health facilities is encouraged especially by health…”
Get full text

6070 Pattern of bevacizumab use in 1st-line therapy metastatic colorectal cancer (mCRC) in real-life practice: results of the ETNA cohort study by Smith, D, Rouyer, M, Balestra, A, Jayles, D, Guimbaud, R, Michel, P, Bernard, O, Ravaud, A, Moore, N, Fourrier-Réglat, A

Get full text

Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C study by LECHEVALLIER-MICHEL, Nathalie, GAUTIER-BERTRAND, Marion, ALPEROVITCH, Annick, BERR, Claudine, BELMIN, Joël, LEGRAIN, Sylvie, SAINT-JEAN, Olivier, TAVERNIER, Béatrice, DARTIGUES, Jean-Francois, FOURRIER-REGLAT, Annie

“…To estimate the frequency of potentially inappropriate medication use among community-dwelling elderly subjects and to identify socio-demographic factors…”
Get full text

O-074: Antidepressant use and cognitive decline in elderly people by Carriere, I, Farre, A, Norton, J, Wyart, M, Noize, P, Peres, K, Fourrier-Reglat, A, Ancelin, M.L

Get full text

Use of Cetuximab (CTX) in 1st-Line Therapy of Metastatic Colorectal Cancer (MCRC): Patient Characteristics, Safety and Effectiveness in the Erebus Cohort by Smith, D., Rouyer, M., Mitry, E., Francois, E., Monnereau, A., Sa-Cunha, A., Jove, J., Noize, P., Moore, N., Fourrier-Réglat, A.

Get full text

649 - Use of Cetuximab (CTX) in 1st-Line Therapy of Metastatic Colorectal Cancer (MCRC): Patient Characteristics, Safety and Effectiveness in the Erebus Cohort by Smith, D., Rouyer, M., Mitry, E., Francois, E., Monnereau, A., Sa-Cunha, A., Jove, J., Noize, P., Moore, N., Fourrier-Réglat, A.

“…CTX has demonstrated improved survival outcomes in mCRC but information in real-life is sparse. EREBUS is a French multicentre cohort with 92 centres. Patients…”
Get full text